» Articles » PMID: 33408897

Cytotoxic Effect of Bee () Venom on Cancer Cell Lines

Overview
Date 2021 Jan 7
PMID 33408897
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Nowadays cancer treatment is an important challenge in the medical world that needs better therapies. Many active secretions produced by insects such as honey bees used to discover new anticancer drugs. Bee venom (BV) has a potent anti inflammatory, anti cancer and tumor effects. The aim of present study is evaluation of anticancer effects induced by venom (AmV) on cell Lines.

Methods: AmV was selected for study on cancer cell lines. Total protein, molecular weight and LD of crude venom were determined. Then, cells were grown in Dulbecco's Modified Eagle medium supplemented with 10% fetal bovine serum and 1% antibiotics. The A, HeLa and MDA-MB-231 cell Lines were exposed by different concentration of AmV. The morphology of cells was determined and cell viability was studed by MTT assay. Evaluation of cell death was determined by and DNA fragmentation.

Results: The results from MTT assay showed that 3.125 µg/mL of A, 12.5 for HeLa and 6.25 µg/mL of MDA-MB-231 killed 50% of cells (p < 0.05). Morphological analysis and the results from hoescht staining and DNA fragmentation indicated that cell death induced by AmV was significantly apoptosis.

Conclusion: The data showed that using lower dosage of AmV during treatment period cause inhibition of proliferation in time and dose dependant manner. Findings indicated that some ingredients of AmV have anticancer effects and with further investigation it can be used in production of anticancer drugs.

Citing Articles

Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review.

Sadek K, Shib N, Taher E, Rashed F, Shukry M, Atia G Front Pharmacol. 2024; 15:1412245.

PMID: 39092234 PMC: 11291246. DOI: 10.3389/fphar.2024.1412245.


Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation.

Pinto M, Pires P, Calhelha R, Silva A, Sousa M, Vilas-Boas M Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794142 PMC: 11123916. DOI: 10.3390/ph17050572.


Cytotoxicity and Radiosensitizing Potentials of Pilosulin-3, a Recombinant Ant Venom, in Breast Cancer Cells.

Alzeer R, Al-Hadyan K, Al-Harbi N, Bin Judia S, Almeer R, Alsbeih G Toxins (Basel). 2023; 15(12).

PMID: 38133205 PMC: 10747674. DOI: 10.3390/toxins15120701.


Can Bee Venom Be Used as Anticancer Agent in Modern Medicine?.

Malek A, Strzemski M, Kurzepa J, Kurzepa J Cancers (Basel). 2023; 15(14).

PMID: 37509375 PMC: 10378503. DOI: 10.3390/cancers15143714.


Bee Venom Triggers Autophagy-Induced Apoptosis in Human Lung Cancer Cells via the mTOR Signaling Pathway.

Yu J, Kim Y, Hong D, Lee D, Chang J, Yoo S J Oncol. 2023; 2022:8916464.

PMID: 36590307 PMC: 9803572. DOI: 10.1155/2022/8916464.


References
1.
Park M, Choi M, Kwak D, Oh K, Yoon D, Han S . Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. Prostate. 2011; 71(8):801-12. DOI: 10.1002/pros.21296. View

2.
Liu S, Yu M, He Y, Xiao L, Wang F, Song C . Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology. 2008; 47(6):1964-73. DOI: 10.1002/hep.22240. View

3.
Hossen M, Mahfuza Shapla U, Gan S, Khalil M . Impact of Bee Venom Enzymes on Diseases and Immune Responses. Molecules. 2016; 22(1). PMC: 6155781. DOI: 10.3390/molecules22010025. View

4.
Babaie M, Zolfagharian H, Zolfaghari M, Jamili S . Biochemical, Hematological Effects and Complications of Pseudosynanceia Melanostigma Envenoming. J Pharmacopuncture. 2019; 22(3):140-146. PMC: 6820475. DOI: 10.3831/KPI.2019.22.018. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View